Quantification of Genotoxic Impurities by HPLC in Active Pharmaceutical Ingredient Lorazepam

被引：0
|
作者：
Panga Chinna
Shet Prakash M.
Ramesha Andagar Ramakrishna
Swamy Sreenivasa
Yashbir Singh
机构：
[1] Department of Studies and Research in Chemistry,
[2] Tumkur University,undefined
[3] RL Fine Chem Pvt Ltd,undefined
[4] Department of Chemistry,undefined
[5] University College of Science,undefined
[6] Tumkur University,undefined
[7] National Assessment and Accreditation Council,undefined
来源：
Journal of Analytical Chemistry | 2023年 / 78卷
关键词：
genotoxic impurity; validation; lorazepam; high performance liquid chromatography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：514 / 521
页数：7
相关论文
共 50 条
  • [21] A comprehensive stability-indicating HPLC method for determination of chloroquine in active pharmaceutical ingredient and tablets: Identification of oxidation impurities
    Coelho, Ana Silva
    Pontes Chagas, Clara Elisa
    de Padua, Rodrigo Maia
    Pianetti, Gerson Antonio
    Fernandes, Christian
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 145 : 248 - 254
  • [22] Chemometrically assisted development and validation of LC-MS/MS method for the analysis of potential genotoxic impurities in meropenem active pharmaceutical ingredient
    Grigori, Katerina
    Loukas, Yannis L.
    Malenovic, Andelija
    Samara, Vicky
    Kalaskani, Anastasia
    Dimovasili, Efi
    Kalovidouri, Magda
    Dotsikas, Yannis
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2017, 145 : 307 - 314
  • [23] Simultaneous multianalyte trace-level quantification of eight genotoxic nitrosamine impurities in valsartan Active Pharmaceutical Ingredient and tablet formulation using UFLC-MS/MS and greenness assessment
    Vikram, P. R. Hemanth
    Kumar, Gunjan
    Deka, Rajashree
    Beeraka, Narasimha M.
    Kandula, Dilipkumar Reddy
    Gorti, Santosh Kapil Kumar
    Bannimath, Namitha
    Kumar, Pramod
    Kumar, Tegginamath Pramod
    Nikolenko, Vladmir N.
    Gurupadayya, Bannimath
    MICROCHEMICAL JOURNAL, 2024, 207
  • [24] Overview of Genotoxic Impurities in Pharmaceutical Development
    Bercu, Joel P.
    Dobo, Krista L.
    Gocke, Elmar
    McGovern, Timothy J.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 (06) : 468 - 478
  • [25] HPLC-MS Analysis of Four Potential Genotoxic Impurities in Alogliptin Pharmaceutical Materials
    Al-Sabti, Bashar
    Harbali, Jehad
    JOURNAL OF AOAC INTERNATIONAL, 2022, 105 (02) : 362 - 369
  • [26] Influence of impurities on the solution-mediated phase transformation of an active pharmaceutical ingredient
    Mukuta, T
    Lee, AY
    Kawakami, T
    Myerson, AS
    CRYSTAL GROWTH & DESIGN, 2005, 5 (04) : 1429 - 1436
  • [27] A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient
    Thomas, Saji
    Shandilya, Sanjeev
    Bharti, Amber
    Agarwal, Ashutosh
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 58 : 136 - 140
  • [28] Determination of genotoxic impurities monomethyl sulfate and dimethyl sulfate in active pharmaceutical ingredients
    Rahman, Mona Hamdy Abdel
    Gullick, Darren R.
    Hoerner, Joshua
    Bartlett, Michael G.
    ANALYTICAL METHODS, 2017, 9 (07) : 1112 - 1118
  • [29] Determination of Potential Genotoxic Impurity, 5-Amino-2-Chloropyridine, in Active Pharmaceutical Ingredient Using the HPLC-UV System
    Soyseven, Murat
    Kecili, Rustem
    Aboul-Enein, Hassan Y.
    Arli, Goksel
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2021, 59 (03) : 241 - 245
  • [30] HPLC determination of lorazepam and lorazepam-related compounds in pharmaceutical formulations
    Orlovic, D
    Radulovic, D
    Ivanovic, D
    Vujic, Z
    CHROMATOGRAPHIA, 2000, 52 (11-12) : 732 - 734
12345